University of Alabama at Birmingham: Breast Neoplasms trials

The registry lists 40 Breast Neoplasms studies with University of Alabama at Birmingham as lead sponsor. 6 are open to participants now and 12 have results posted.

Early Phase 1 1Phase 1 7Phase 2 12No phase 22(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE StudyRecruitingNCT07671937Not applicable
• Mind-Body Group Interventions for Psychological Distress in Young Breast Cancer SurvivorsRecruitingNCT07501637Not applicable
• Video-Conferenced Stress Management and Relaxation Training (VSMART) For Alabama Breast Cancer SurvivorsEnrolling by invitationNCT06924788Not applicable
• Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon SatisfactionRecruitingNCT06294574Not applicable
• Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast CancerRecruitingNCT06105684Phase 2
• Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy EffectivenessRecruitingNCT03321045Early Phase 1
• Promoting Resilience in Women With Breast CancerCompletedNCT06133348Not applicableResults posted
• Identifying Ideal Reimbursement "Dose" to Reduce Clinical Trial-related Financial ToxicityCompletedNCT05871125Not applicableResults posted
• Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthCompletedNCT04000880Not applicableResults posted
• Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMDTerminatedNCT03501979Phase 2Results posted
• Study of Dual-energy (DE) Contrast-enhanced (CE) Digital MammographyCompletedNCT02995980Not applicableResults posted
• Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast CancerCompletedNCT02520063Phase 1/2Results posted
• Breast VCEUS to Evaluate Early Response to Neoadjuvant ChemotherapyTerminatedNCT01817374Not applicableResults posted
• Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast CancerCompletedNCT01307891Phase 2Results posted
• Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer SurvivorsActive, not recruitingNCT01196936Phase 2Results posted
• Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With AvastinCompletedNCT00635050Phase 2Results posted
• Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast CancerCompletedNCT00530868Phase 2Results posted
• Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.CompletedNCT00240071Phase 2Results posted
• Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC)CompletedNCT06006299Phase 1
• Interventions to Decrease Financial ToxicityCompletedNCT05939440Not applicable
• Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer SurvivorsTerminatedNCT05452681Not applicable
• Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved PopulationsCompletedNCT05000502Not applicable
• Molecular Neuroimaging to Assess the Link Between Neuroinflammation and Cognitive Impairment in Breast CancerWithdrawnNCT04364672Phase 1
• Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose ReductionCompletedNCT04340180Phase 1
• Gut Microbe Composition, Exercise, and Breast Breast Cancer SurvivorsActive, not recruitingNCT04088708Not applicable
• Enhancing Shared Decision-Making in Breast CancerCompletedNCT03806738Not applicable
• RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)Active, not recruitingNCT03643861Not applicable
• Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast CancerActive, not recruitingNCT03368729Phase 1/2
• Understanding Value in Metastatic Breast CancerCompletedNCT03257917
• Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)CompletedNCT03248258
• Simulated-altitude to Optimize Aerobic Exercise Among Breast Cancer Survivors With Limited MobilityCompletedNCT03029182Not applicable
• Physical Activity, Fatigue, Sleep, and InflammationCompletedNCT01147367Not applicable
• Collecting Information From Patients Enrolled in the Breast Specialized Program of Research ExcellenceCompletedNCT01004562
• Enhancing Physical Activity Adherence After Breast Cancer Diagnosis (BEAT Cancer II)CompletedNCT00929617Not applicable
• An Exercise Intervention for Breast Cancer Patients: Feasibility and Effectiveness (BEAT Cancer Trial; Pilot Study)CompletedNCT00721565Phase 1
• Changes in Cancer-related Cytokines After Participation in a Physical Activity Behavior Change Intervention (CICK Study)CompletedNCT00640666Not applicable
• Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast CancerCompletedNCT00161291Phase 2
• Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast CancerCompletedNCT00096343Phase 2
• CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00033384Phase 2
• Vaccine Therapy in Treating Patients With Metastatic or Recurrent CancerWithdrawnNCT00017537Phase 1